# Purple Heart Reishi (Ganoderma lucidum 'Purple Heart')

**Canonical URL:** https://ingredients.hermeticasuperfoods.com/ingredients/purple-heart-reishi
**Data Source:** Hermetica Superfoods Ingredient Encyclopedia
**Updated:** 2026-04-01
**Evidence Score:** 2 / 10
**Category:** Mushroom/Fungi
**Also Known As:** Ganoderma lucidum 'Purple Heart', Purple Heart Lingzhi, Purple Reishi, Purple Lingzhi, Ganoderma lucidum cv. Purple Heart, Purple Heart Medicinal Mushroom

## Overview

Purple Heart Reishi (Ganoderma lucidum 'Purple Heart') is a cultivated variant of standard reishi mushroom whose bioactive polysaccharides—including ganoderans A, B, and C—are presumed to modulate [immune function](/ingredients/condition/immune-support) via macrophage and NK cell activation. No clinical trials have been conducted on this specific variant; available evidence derives entirely from preclinical studies on the parent species G. lucidum.

## Health Benefits

• No clinical evidence available - research limited to standard G. lucidum showing preclinical immunostimulating effects from polysaccharides (ganoderans A, B, C)
• No human trials documented - preclinical models suggest potential antitumor activity from beta-glucans
• No clinical data - traditional use suggests [immune support](/ingredients/condition/immune-support) but lacks modern validation
• No human studies found - preclinical evidence indicates possible [anti-inflammatory](/ingredients/condition/inflammation) effects from triterpenes
• No clinical trials available - historical use for vitality lacks contemporary research support

## Mechanism of Action

The [beta-glucan](/ingredients/condition/immune-support)s and ganoderans (A, B, C) found in G. lucidum variants bind to Dectin-1 and complement receptor 3 (CR3) on macrophages and dendritic cells, triggering NF-κB and MAPK signaling cascades that upregulate [pro-inflammatory cytokine](/ingredients/condition/inflammation)s including TNF-α, IL-6, and IL-12. Triterpene acids such as ganoderic acid A inhibit 5-alpha reductase and HMG-CoA reductase activity in preclinical models, while also suppressing tumor cell proliferation by inducing caspase-3-mediated apoptosis. These mechanisms are extrapolated from standard G. lucidum research and have not been confirmed specifically for the 'Purple Heart' cultivar.

## Clinical Summary

No human clinical trials have been conducted specifically on the Purple Heart cultivar of Ganoderma lucidum. Evidence is extrapolated from studies on standard G. lucidum, where randomized controlled trials involving 36–132 participants have demonstrated modest immunostimulating effects, including increased [NK cell](/ingredients/condition/immune-support) activity and elevated serum IgG levels. Preclinical rodent studies on G. lucidum polysaccharides have shown antitumor activity measured by tumor volume reduction, but these results have not been replicated in human oncology trials. Overall evidence quality for any G. lucidum variant remains low-to-moderate by GRADE criteria, and no efficacy claims can responsibly be made for Purple Heart Reishi specifically.

## Nutritional Profile

Purple Heart Reishi is a cultivar of Ganoderma lucidum and shares the general nutritional and phytochemical profile of the species, as no cultivar-specific compositional analyses have been published. Based on data from standard G. lucidum fruiting bodies and extracts: **Macronutrients (per 100 g dried fruiting body, approximate):** Protein 7–18 g (containing all essential amino acids, though in modest amounts; digestibility moderate due to chitin-rich cell walls), Total carbohydrates 24–58 g (dominated by polysaccharides, including beta-glucans at roughly 10–30% of dry weight), Crude fat 1.5–5 g (including ergosterol at ~0.3–0.6 g, which converts to vitamin D2 upon UV exposure), Dietary fiber (chitin and beta-glucans) 25–50 g, Ash 1–2 g. Caloric value approximately 200–350 kcal/100 g dry weight. **Key Bioactive Polysaccharides:** Beta-D-glucans (particularly (1→3)(1→6)-β-D-glucans) at approximately 10–30 g/100 g dry weight; ganoderans A, B, and C (heteropolysaccharides with glucose, galactose, mannose backbones); water-soluble polysaccharide–protein complexes (GL-1, GLPS) with reported immunostimulatory activity. Bioavailability of beta-glucans is limited by chitin matrix; hot-water extraction increases accessibility significantly (extraction yields ~1.5–5% by weight as crude polysaccharide). **Triterpenoids (Ganoderic Acids):** Over 150 lanostane-type triterpenoids identified in G. lucidum; total triterpene content approximately 1–5 g/100 g dry weight. Major compounds include ganoderic acids A, B, C₂, D, F, G, H (each typically 0.01–0.3% dry weight individually), lucidenic acids A, B, C, and ganodermanontriol. These are ethanol/lipid-soluble; oral bioavailability is low without dual extraction (hot water + ethanol) or lipid co-administration. The 'Purple Heart' cultivar name implies potentially elevated pigment-associated triterpenoid content, but this is unverified analytically. **Minerals (per 100 g dried):** Potassium 200–700 mg, Phosphorus 100–350 mg, Calcium 30–80 mg, Magnesium 20–60 mg, Iron 2–15 mg, Zinc 3–9 mg, Selenium 1–7 µg (highly substrate-dependent), Copper 1–3 mg, Germanium (organic, trace — often cited in traditional literature at 0.01–0.05 mg but varies enormously with substrate). **Vitamins:** B-complex vitamins present in modest amounts — Niacin (B3) 3–8 mg, Riboflavin (B2) 0.5–2 mg, Thiamine (B1) 0.1–0.3 mg, Pantothenic acid (B5) 1–3 mg per 100 g dry weight. Ergosterol (provitamin D2) at ~300–600 mg/100 g converts to vitamin D2 with UV-B irradiation. Vitamin C and fat-soluble vitamins (A, E, K) are negligible or absent. **Other Bioactive Compounds:** Peptidoglycans (LZ-8 [immunomodulatory](/ingredients/condition/immune-support) protein, ~12.4 kDa), small amounts of adenosine and related nucleosides (~0.01–0.1%), sterols (ergosterol peroxide with reported cytotoxic activity), and phenolic compounds (total phenolics ~5–15 mg GAE/g in aqueous extracts). **Bioavailability Notes:** Raw or minimally processed fruiting bodies have poor bioavailability due to chitin cell walls; traditional decoction (hot-water simmering 1–2 hours) liberates polysaccharides effectively, while ethanol extraction is required for triterpenoids. Dual-extraction preparations capture the broadest spectrum of bioactives. Protein digestibility is enhanced by fine milling or enzymatic processing. Beta-glucan immunological activity depends on molecular weight (>100 kDa fractions most active) and is partially degraded by gastric conditions, with gut-associated lymphoid tissue (GALT) uptake via M-cells and Dectin-1 receptor binding being the primary mechanism of immune activation. No cultivar-specific ('Purple Heart') quantitative compositional data currently exists in peer-reviewed literature; all values extrapolated from standard G. lucidum research.

## Dosage & Preparation

No clinically studied dosage ranges are available for Purple Heart Reishi or standardized G. lucidum forms. Commercial products show variable compositions of polysaccharides and triterpenes, but lack standardization data. Consult a healthcare provider before starting any new supplement.

## Safety & Drug Interactions

Based on data from standard G. lucidum, reishi mushroom products are generally well tolerated at doses of 1.5–9 g/day of dried extract for periods up to 16 weeks, with the most commonly reported adverse effects being gastrointestinal discomfort, dry mouth, and dizziness. Reishi may potentiate anticoagulant and antiplatelet drugs—including warfarin and aspirin—by inhibiting platelet aggregation, warranting clinical monitoring of INR in affected patients. Immunosuppressant drug interactions are theoretically possible given reishi's immune-activating properties, posing a concern for organ transplant recipients on cyclosporine or tacrolimus. Pregnancy and breastfeeding safety has not been established for any G. lucidum variant including Purple Heart, and use is not recommended in these populations.

## Scientific Research

No human clinical trials, RCTs, or meta-analyses were found specifically for Purple Heart Reishi or standard G. lucidum in the available research. Evidence is limited to preclinical models with no PubMed PMIDs cited for human studies.

## Historical & Cultural Context

Ganoderma lucidum (lingzhi) has been used in Traditional Chinese Medicine for over 2,000 years as a tonic for vitality, [longevity](/ingredients/condition/longevity), and [immune support](/ingredients/condition/immune-support), typically prepared as teas or decoctions. While prized in East Asian systems for calming the spirit and supporting heart and lung function, no historical use specific to the 'Purple Heart' cultivar is documented.

## Synergistic Combinations

Standard reishi, cordyceps, turkey tail, vitamin D3, astragalus

## Frequently Asked Questions

### What makes Purple Heart Reishi different from regular reishi mushroom?

Purple Heart Reishi is a specific cultivar of Ganoderma lucidum selected or bred for distinct morphological traits, including pigmentation, but no published research has characterized whether its polysaccharide or triterpene content differs quantitatively from standard G. lucidum. All purported benefits—including immune modulation via ganoderans A, B, and C—are extrapolated from studies on the parent species. Until cultivar-specific phytochemical and clinical analyses are published, Purple Heart Reishi cannot be distinguished from standard reishi on an evidence basis.

### Is there any clinical evidence that Purple Heart Reishi boosts the immune system?

No human trials have been conducted on Purple Heart Reishi specifically. Trials on standard G. lucidum involving 36–132 participants have reported increases in NK cell cytotoxicity and serum immunoglobulin levels, but effect sizes have been modest and study quality variable. These findings cannot be directly attributed to the Purple Heart cultivar without independent research confirming comparable bioactive compound profiles.

### What is the recommended dosage for Purple Heart Reishi supplements?

No dosage has been established for Purple Heart Reishi due to the complete absence of clinical trials for this cultivar. Dosage guidance for standard G. lucidum in research settings ranges from 1.5 g to 9 g per day of dried mushroom extract, typically standardized to polysaccharide content of 10–30%. Consumers should treat any labeled dosage for Purple Heart Reishi as manufacturer-derived rather than evidence-based, and consult a healthcare provider before use.

### Can Purple Heart Reishi interact with blood thinners like warfarin?

Based on data from standard Ganoderma lucidum, reishi mushroom extracts may inhibit platelet aggregation through adenylate cyclase pathway modulation, potentially amplifying the anticoagulant effect of warfarin, heparin, or antiplatelet agents like clopidogrel. One case report documented elevated INR in a patient combining G. lucidum with warfarin. Patients on anticoagulant therapy should not add any reishi supplement, including Purple Heart Reishi, without medical supervision and regular INR monitoring.

### Does Purple Heart Reishi have anti-cancer properties?

Preclinical studies on G. lucidum beta-glucans and ganoderic acid A have demonstrated antitumor activity in rodent models, including caspase-3-mediated apoptosis induction and tumor volume reduction, but no human oncology trials have validated these findings for any reishi cultivar including Purple Heart. The U.S. FDA has not approved any G. lucidum product as a cancer treatment or adjunct therapy. Any anti-cancer claims for Purple Heart Reishi are unsupported by clinical evidence and should not influence treatment decisions.

### How does Purple Heart Reishi compare to other reishi cultivars in terms of bioactive compound concentration?

Purple Heart Reishi is a specific cultivar variant of Ganoderma lucidum, but there are no published comparative studies directly measuring polysaccharide or beta-glucan levels between this cultivar and standard reishi strains. Most existing research focuses on G. lucidum as a species rather than individual cultivar variants, making it difficult to establish whether the 'Purple Heart' designation correlates with higher bioactive content. Consumers should note that cultivar differences, if any, have not been documented in peer-reviewed clinical literature.

### Is Purple Heart Reishi safe to use long-term as a daily supplement?

Standard reishi (G. lucidum) has a long history of traditional use and is generally considered safe for long-term consumption, with few reported adverse effects in traditional medicine systems. However, no human safety trials specifically document the long-term use profile of Purple Heart Reishi as a distinct cultivar variant. Anyone considering daily long-term use should consult a healthcare provider, particularly if they take anticoagulants or have bleeding disorders, as reishi species may have mild anticoagulant properties.

### What is the research status on Purple Heart Reishi's active compounds compared to standard reishi extracts?

The current evidence base for Purple Heart Reishi specifically is extremely limited, with no dedicated clinical trials or chemical analyses published for this cultivar variant. All available scientific support for reishi's bioactive compounds—such as polysaccharides (ganoderans A, B, C) and beta-glucans—comes from studies on standard Ganoderma lucidum, not the Purple Heart variant specifically. To understand this ingredient's actual efficacy, consumers should rely on evidence from general reishi research rather than cultivar-specific claims, since cultivation differences have not been scientifically validated.

---

*Source: Hermetica Superfoods Ingredient Encyclopedia — https://ingredients.hermeticasuperfoods.com*
*License: CC BY-NC-SA 4.0 — Attribution required. Commercial use: admin@hermeticasuperfoods.com*